Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,98 € ↑2,18 (3,53%)
2026-06-04
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionBurney Co/
Latest Disclosed Ownership45,779 shares
Latest Disclosed Value $ 1,845,351
Burney Co/ reports 79.55% decrease in ownership of HTD / Corcept Therapeutics Incorporated

On April 29, 2026 - Burney Co/ filed a 13F-HR form disclosing ownership of 45,779 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $1,578,918 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 223,837 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -79.55% during the quarter. The current value of the position is $2,928,940 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 45,779 -178,058 -79.55 1,845 -76.31 0.0471
2026-01-23 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 223,837 -6,928 -3.00 7,790 -59.39 0.2429
2025-10-16 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 230,765 -19,381 -7.75 19,179 4.46 0.6100
2025-08-05 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 250,146 -16,251 -6.10 18,361 -39.66 0.6214
2025-05-06 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 266,397 -207,424 -43.78 30,428 27.44 1.1071
2025-01-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 473,821 39,657 9.13 23,876 18.82 0.8437
2024-10-18 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 434,164 17,366 4.17 20,093 48.39 0.7147
2024-07-29 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 416,798 -14,840 -3.44 13,542 24.55 0.5174
2024-05-22 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 431,638 12,402 2.96 10,873 -20.15 0.4143
2024-02-12 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 419,236 17,973 4.48 13,617 24.55 0.5731
2023-11-08 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 401,263 115,006 40.18 10,932 71.64 0.5123
2023-08-09 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 286,257 -612 -0.21 6,369 2.51 0.2920
2023-05-10 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 286,869 -9,452 -3.19 6,214 3.24 0.3062
2023-02-06 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 296,321 -94,959 -24.27 6,018 -40.01 0.3048
2022-11-15 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 391,280 50,792 14.92 10,032 23.90 0.5537
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 340,488 -9,492 -2.71 8,097 2.73 0.4260
2022-05-09 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 349,980 -1,596 -0.45 7,882 13.23 0.3235
2022-05-09 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 342,609 7,716
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 351,576 -31,600 -8.25 6,961 -7.69 0.3005
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 383,176 -3,432 -0.89 7,541 -11.34 0.3540
2021-08-06 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 386,608 8,781 2.32 8,506 -5.37 0.3957
2021-05-13 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 377,827 9,796 2.66 8,989 -6.63 0.4433
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 368,031 21,573 6.23 9,627 59.65 0.5282
2020-12-14 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 346,458 79,649 29.85 6,030 34.36 0.3736
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 266,809 266,809 4,488 0.2912
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.